Accéder au contenu
Merck

The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.

Bioorganic & medicinal chemistry letters (2006-07-28)
Donald L Hertzog, Kamal A Al-Barazanji, Eric C Bigham, Michael J Bishop, Christy S Britt, David L Carlton, Joel P Cooper, Alex J Daniels, Dulce M Garrido, Aaron S Goetz, Mary K Grizzle, Yu C Guo, Anthony L Handlon, Diane M Ignar, Ronda O Morgan, Andrew J Peat, Francis X Tavares, Huiqiang Zhou
RÉSUMÉ

Optimization of a series of constrained melanin-concentrating hormone receptor 1 (MCH R1) antagonists has provided compounds with potent and selective MCH R1 activity. Details of the optimization process are provided and the use of one of the compounds in an animal model of diet-induced obesity is presented.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Methyl 3-amino-2-thiophenecarboxylate, 99%